California · Nonprofit
THE FOUNDATION TO ADVANCE VASCULAR CURES
THE FOUNDATION TO ADVANCE VASCULAR CURES (California) receives grants from 22 organizations whose IRS filings report $2,136,373 to it, the largest being WILLIAM K BOWES JR FOUNDATION ($600,000). 14 of them have funded it in more than one year.
- Revenue FY2024
- $1.9M
- Funders on record
- 22
- Grants received
- $2.1M
- Net assets
- $4.1M
What The Foundation to Advance Vascular Cures does
Mission
Our mission: to achieve better vascular health for all through a patient-centric approach to research and education. Our vision: a world where everyone experiences healthy vascular systems - the arteries and veins that support the effective functioning of all the body's organs.
As stated on its FY2024 Form 990.
Programs
We serve as a catalyst for innovative programs that show high potential to effect systemic change in vascular disease. We do this through convenings, such as the vascular health innovation summit and clti/pad working groups, and incubation and resource support for emerging programs, such as champions (a national intiative that supports community-based screening, awareness raising, capacity-building, and research in pad). Project voice and fiscal sponsorship of alps are examples of previous instances where we have served in a catalyzing capacity.
$529,731 spentof which $319,218 as grants$276,615 earned by the program61% of program spendingEducation and community awareness programs raise awareness of the risks, consequences, and new treatments for vascular disease. We emphasize empowerment and shared decision-making best practices, helping to ensure that patients with vascular disease and their families are equipped with the knowledge to make informed decisions about their health care. We have a specific focus on prevention and making resources accessible to vulnerable populations and communities. Every year, more than 200,000 individuals around the world visit our website to learn about vascular disease and connect to critical resources.
$264,145 spent30% of program spendingThe wylie scholar award and the collaborative patient-centered research award provide career research grants that advance innovation in vascular research. The wylie scholar award is granted to outstanding young vascular surgeon-scientists who combine active patient care with academic research. The award supports crucial patient-centered research that enables them to compete for future research funding. Wylie scholars become north america's world-class vascular surgeon-scientists; many are now chiefs at major academic centers, prominent leaders in the field. Since 1996, we've supported 25 surgeon-scientists at 16 institutions around the country who are transforming patient care. The average return on investment for follow-on research funding is 30:1. The collaborative patient centered research award provides support for projects that offer innovative approaches with direct patient impact and are multi-institutional and responsive to the priorities identified at our annual vascular health innovation summit.
$74,202 spentof which $50,000 as grants9% of program spending
The 3 programs described on its FY2023 Form 990, listed largest first by expense. Program spending in total: $868,078.
The organization over time
Each line starts at 100 in 2017, so what you read is the shape rather than the size: 150 means half as much again as 2017, 50 means half. The number beside each label in the key is where it ended.
Balance sheet
Total assets and total liabilities at each year end, in dollars. The largest one-year move in total assets was 2023 to 2024, from $3.6M to $4.3M (+21%).
How it's funded, over time
Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.
Government-grant reliance: 2021 11% · 2023 8%. Grants only. Government contracts and fees sit inside program revenue.
Surplus & reserves
Operating surplus or deficit each year, and months of liquidity in hand. 4 of the last 8 reported years ran a deficit.
reserve
Leadership and staff
The officers, directors, trustees and key employees listed on each return. Joined and no longer listed compare each filing with the year before, matching people by surname and first initial; a year after a gap, or a roster under three people, has no comparison.
Chief executive
Isabel Bjork
Secretary, CEO
As listed on its FY2024 Form 990.
The chief executive listed changed between the FY2022 and FY2023 filings.
Who funds it, year by year
2017 → 2023: the base held at 10 funders, grant income rose $46k → $292k.
5 of 22 of your funders are donor-advised or pass-through sponsors (tagged DAF) — 18% of grant dollars received. That money is really individual donors directing a sponsor; the institutions to cultivate are the non-DAF funders.
From the IRS filings of THE FOUNDATION TO ADVANCE VASCULAR CURES’s funders (the co-funder graph). Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
How concentrated its funding is
THE FOUNDATION TO ADVANCE VASCULAR CURES has a broad base — no single funder exceeds 28% of grant income, and it takes 3 funders to reach half.
the vertical line marks half of all grant income — 3 funders to its left
Largest funder’s share by year: 2017 32% · 2018 86% · 2019 65% · 2020 62% · 2021 53% · 2022 43% · 2023 33% — broadly stable.
“Effective funders” = inverse Herfindahl index (1 / Σ shareᵢ²) — the number of equal-sized funders that would give the same concentration. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
How long its funders stay
31% of THE FOUNDATION TO ADVANCE VASCULAR CURES's funders are still giving 3 years after their first grant; 64% give in more than one year at all.
Share of funders still giving k years after their first recorded grant, pooled across every acquisition cohort. A funder counts as retained in a year only if it made a grant that year. Measured to FY2023, the last fiscal year that has finished arriving — a funder cannot be counted as lapsed in a year most filers have not reached.
Where its funders are
89% of THE FOUNDATION TO ADVANCE VASCULAR CURES's grant income comes from California funders.
In-state vs out-of-state, by year
Funder states come from each funder’s own filing. $379k arriving through sponsors registered in 5 states is excluded from the map and the split above: a sponsor holds money on a donor’s behalf, so its registered address would place those dollars somewhere no donor need ever have been. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
Organizations like THE FOUNDATION TO ADVANCE VASCULAR CURES
Organizations whose mission and program text most resemble this one, by semantic similarity over every organization in the US filings — the closest peers, and often the clearest route to shared or prospective funders.
In California
Nationally
Read directly from this organization’s own Form 990, as neutral context.
Where the money goes
78% of spending goes to programs.
Governance
Public support
66%
Share of support from the public (Schedule A) — the basis for its public-charity status.
Footprint & structure
Files a return copy in 1 state
Screen this organization
A dated, signed PDF of the compliance screen for THE FOUNDATION TO ADVANCE VASCULAR CURES: IRS status (Business Master File, Publication 78, auto-revocation), the OFAC sanctions lists, the Internal Revenue Bulletin, and California registration, with the Rev. Proc. 2018-32 §8.01 reliance elements stated element by element. Generated from the current files at the moment you download it.
Screens are triage, not determinations; a source that cannot be read reports not screened, never clear. Screen this nonprofit · How the screen works · on the API as GET /api/screening/{ein}?format=pdf
Questions and answers
- Who funds THE FOUNDATION TO ADVANCE VASCULAR CURES?
- THE FOUNDATION TO ADVANCE VASCULAR CURES (California) receives grants from 22 organizations whose IRS filings report $2,136,373 to it, the largest being WILLIAM K BOWES JR FOUNDATION ($600,000). 14 of them have funded it in more than one year.
- How many funders does THE FOUNDATION TO ADVANCE VASCULAR CURES have?
- IRS filings report 22 organizations giving $2,136,373 in grants to THE FOUNDATION TO ADVANCE VASCULAR CURES, 14 of which have funded it in more than one year.
- Who is the largest funder of THE FOUNDATION TO ADVANCE VASCULAR CURES?
- WILLIAM K BOWES JR FOUNDATION is the largest funder on record, with $600,000 in grants. The full list of funders is on this page.
- How can an organization like THE FOUNDATION TO ADVANCE VASCULAR CURES find more funders?
- Start with the funders already giving here, then look at the foundations that back similar organizations in California. The funding by cause and by state pages list the largest funders for a given area and how to approach them.
These figures are read directly from IRS Form 990 / 990-PF e-file XML: this organization’s own return for FY2024 (financials across 2017–2024), and the filings of 22 funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported October 14, 2026. What this page cannot tell you · view filing